Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 274

1.

Cancer randomised trials showed that dissemination bias is still a problem to be solved.

Urrútia G, Ballesteros M, Djulbegovic B, Gich I, Roqué M, Bonfill X.

J Clin Epidemiol. 2016 May 6. pii: S0895-4356(16)30125-1. doi: 10.1016/j.jclinepi.2016.04.011. [Epub ahead of print]

PMID:
27164275
2.

Thrombotic thrombocytopenic purpura: gaining knowledge.

Bennett CL, Djulbegovic B.

Lancet Haematol. 2016 May;3(5):e210-1. doi: 10.1016/S2352-3026(16)30028-X. Epub 2016 Apr 16. No abstract available.

PMID:
27132693
3.

NCCN Guidelines Insights: Multiple Myeloma, Version 3.2016.

Anderson KC, Alsina M, Atanackovic D, Biermann JS, Chandler JC, Costello C, Djulbegovic B, Fung HC, Gasparetto C, Godby K, Hofmeister C, Holmberg L, Holstein S, Huff CA, Kassim A, Krishnan AY, Kumar SK, Liedtke M, Lunning M, Raje N, Reu FJ, Singhal S, Somlo G, Stockerl-Goldstein K, Treon SP, Weber D, Yahalom J, Shead DA, Kumar R.

J Natl Compr Canc Netw. 2016 Apr;14(4):389-400.

PMID:
27059188
4.

Activating clinical trials: a process improvement approach.

Martinez DA, Tsalatsanis A, Yalcin A, Zayas-Castro JL, Djulbegovic B.

Trials. 2016 Feb 24;17(1):106. doi: 10.1186/s13063-016-1227-2.

5.

GRADE guidelines system is reproducible when instructions are clearly operationalized even among the guidelines panel members with limited experience with GRADE.

Kumar A, Miladinovic B, Guyatt GH, Schünemann HJ, Djulbegovic B.

J Clin Epidemiol. 2016 Jul;75:115-8. doi: 10.1016/j.jclinepi.2015.11.020. Epub 2016 Feb 2.

PMID:
26845745
6.

The role of iron in the management of chemotherapy-induced anemia in cancer patients receiving erythropoiesis-stimulating agents.

Mhaskar R, Wao H, Miladinovic B, Kumar A, Djulbegovic B.

Cochrane Database Syst Rev. 2016 Feb 4;2:CD009624. doi: 10.1002/14651858.CD009624.pub2. Review.

PMID:
26845108
7.

Towards theory integration: Threshold model as a link between signal detection theory, fast-and-frugal trees and evidence accumulation theory.

Hozo I, Djulbegovic B, Luan S, Tsalatsanis A, Gigerenzer G.

J Eval Clin Pract. 2015 Dec 18. doi: 10.1111/jep.12490. [Epub ahead of print]

PMID:
26683386
8.

Rationality, practice variation and person-centred health policy: a threshold hypothesis.

Djulbegovic B, Hamm RM, Mayrhofer T, Hozo I, Van den Ende J.

J Eval Clin Pract. 2015 Dec;21(6):1121-4. doi: 10.1111/jep.12486. Epub 2015 Dec 7.

PMID:
26639018
9.

Rough set theory based prognostic classification models for hospice referral.

Gil-Herrera E, Aden-Buie G, Yalcin A, Tsalatsanis A, Barnes LE, Djulbegovic B.

BMC Med Inform Decis Mak. 2015 Nov 25;15:98. doi: 10.1186/s12911-015-0216-9.

10.

Determining optimal threshold for statins prescribing: individualization of statins treatment for primary prevention of cardiovascular disease.

Djulbegovic B, Tsalatsanis A, Hozo I.

J Eval Clin Pract. 2015 Nov 11. doi: 10.1111/jep.12473. [Epub ahead of print]

PMID:
26555150
11.

Multiple Myeloma, Version 2.2016: Clinical Practice Guidelines in Oncology.

Anderson KC, Alsina M, Atanackovic D, Biermann JS, Chandler JC, Costello C, Djulbegovic B, Fung HC, Gasparetto C, Godby K, Hofmeister C, Holmberg L, Holstein S, Huff CA, Kassim A, Krishnan AY, Kumar SK, Liedtke M, Lunning M, Raje N, Singhal S, Smith C, Somlo G, Stockerl-Goldstein K, Treon SP, Weber D, Yahalom J, Shead DA, Kumar R; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2015 Nov;13(11):1398-435.

12.

Those Responsible for Approving Research Studies Have Poor Knowledge of Research Study Design: a Knowledge Assessment of Institutional Review Board Members.

Mhaskar R, Pathak EB, Wieten S, Guterbock TM, Kumar A, Djulbegovic B.

Acta Inform Med. 2015 Aug;23(4):196-201. doi: 10.5455/aim.2015.23.196-201. Epub 2015 Jul 30.

13.

A number of factors explain why WHO guideline developers make strong recommendations inconsistent with GRADE guidance.

Alexander PE, Gionfriddo MR, Li SA, Bero L, Stoltzfus RJ, Neumann I, Brito JP, Djulbegovic B, Montori VM, Norris SL, Schünemann HJ, Thabane L, Guyatt GH.

J Clin Epidemiol. 2016 Feb;70:111-22. doi: 10.1016/j.jclinepi.2015.09.006. Epub 2015 Sep 21.

PMID:
26399903
14.

Senior GRADE methodologists encounter challenges as part of WHO guideline development panels: an inductive content analysis.

Alexander PE, Li SA, Gionfriddo MR, Stoltzfus RJ, Neumann I, Brito JP, Djulbegovic B, Montori VM, Schünemann HJ, Guyatt GH.

J Clin Epidemiol. 2016 Feb;70:123-8. doi: 10.1016/j.jclinepi.2015.09.003. Epub 2015 Sep 15.

PMID:
26385188
15.

Evidence-based medicine meets person-centred care: a collaborative perspective on the relationship.

Price AI, Djulbegovic B, Biswas R, Chatterjee P.

J Eval Clin Pract. 2015 Dec;21(6):1047-51. doi: 10.1111/jep.12434. Epub 2015 Sep 10.

PMID:
26358758
16.

Value-Based Cancer Care and the Excessive Cost of Drugs.

Djulbegovic B.

JAMA Oncol. 2015 Dec;1(9):1301-2. doi: 10.1001/jamaoncol.2015.3302. No abstract available.

PMID:
26313294
17.

Dual Processing Model for Medical Decision-Making: An Extension to Diagnostic Testing.

Tsalatsanis A, Hozo I, Kumar A, Djulbegovic B.

PLoS One. 2015 Aug 5;10(8):e0134800. doi: 10.1371/journal.pone.0134800. eCollection 2015.

18.

High-dose therapy and autologous hematopoietic cell transplantation as front-line consolidation in chronic lymphocytic leukemia: a systematic review.

Reljic T, Kumar A, Djulbegovic B, Kharfan-Dabaja MA.

Bone Marrow Transplant. 2015 Aug;50(8):1144. doi: 10.1038/bmt.2015.126. No abstract available.

PMID:
26242579
19.

Thinking Styles and Regret in Physicians.

Djulbegovic M, Beckstead J, Elqayam S, Reljic T, Kumar A, Paidas C, Djulbegovic B.

PLoS One. 2015 Aug 4;10(8):e0134038. doi: 10.1371/journal.pone.0134038. eCollection 2015.

20.

Effect of Age on Clinical Outcomes in Phase 1 Trial Participants.

Mahipal A, Denson AC, Djulbegovic B, Lush R, Kumar A, Juan TH, Schell MJ, Sullivan DM.

Cancer Control. 2015 Apr;22(2):235-41.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk